Ignite Creation Date:
2024-05-05 @ 10:45 PM
Last Modification Date:
2024-10-26 @ 10:23 AM
Study NCT ID:
NCT01171417
Status:
COMPLETED
Last Update Posted:
2014-02-27
First Post:
2010-06-23
Brief Title:
A Treatment With Fulvestrant and Exemestane in Postmenopausal Patients With Advanced Hormone Receptor-Positive HR Breast Cancer
Sponsor:
AstraZeneca
Organization:
AstraZeneca